Now that the FDA has forced GlaxoSmithKline (GSK) to put a "black label" on its diabetes drug Avandia, the competition is going for a coup de grace.
Takeda Pharmaceutical Co Ltd said on Thursday it was planning a major U.S. advertising campaign for diabetes drug Actos — one day after a new safety warning was issued on rival product Avandia, according to Reuters. The news service adds "the ads will run in 82 local newspapers and in several news weeklies, starting on Friday, under the headline "Actos has been shown to lower blood sugar without increasing your risk of having a heart attack or stroke.".
Never let it be said that the drug company executives are nice people.
Douglas A. McIntyre
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
